BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 13, 2018
Distillery Techniques

Disease models

BioCentury | Dec 8, 2017
Targets & Mechanisms

Pathways emerging from ASH

An analysis of emerging targets at ASH by mechanism
BioCentury | Dec 8, 2017
Targets & Mechanisms

Epiphenomena at ASH

Epigenetics and cell therapies are preclinical hotspots at ASH 2017
BioCentury | Aug 15, 2016
Clinical News

Tazemetostat: Phase II started

BioCentury | Oct 31, 2011
Company News

Castle Biosciences, Washington University deal

BioCentury | Nov 18, 2010
Distillery Therapeutics

Indication: Cancer

BioCentury | Mar 2, 1998
Company News

The Wistar Institute other research news

Items per page:
1 - 8 of 8